These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2975699)

  • 21. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
    Closse A; Frick W; Markstein R; Maurer R; Nordmann R
    J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen.
    Dawson VL; Dawson TM; Filloux FM; Wamsley JK
    Life Sci; 1988; 42(20):1933-9. PubMed ID: 2966886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.
    De Keyser J; Claeys A; De Backer JP; Ebinger G; Roels F; Vauquelin G
    Neurosci Lett; 1988 Aug; 91(2):142-7. PubMed ID: 2972942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
    Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
    Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters.
    Chester JA; Mullins AJ; Nguyen CH; Watts VJ; Meisel RL
    Psychopharmacology (Berl); 2006 Sep; 188(1):53-62. PubMed ID: 16850118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Perry RH; Crossman AR
    Neurosci Lett; 1994 Mar; 169(1-2):68-72. PubMed ID: 8047295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P; Niznik HB
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of neurotransmitter receptors and neurotransmitter transporters in progressive supranuclear palsy.
    Landwehrmeyer B; Palacios JM
    J Neural Transm Suppl; 1994; 42():229-46. PubMed ID: 7525868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology.
    Cortés R; Camps M; Gueye B; Probst A; Palacios JM
    Brain Res; 1989 Mar; 483(1):30-8. PubMed ID: 2650806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK; Penney JB; Young AB
    Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

  • 36. Coactivation of dopamine D1 and D2 receptors increases the affinity of cholecystokinin-8 receptors in membranes from post-mortem human caudate-putamen.
    von Euler G; Mailleux P; von Euler M; Schiffmann SN; Vanderhaeghen JJ; Fuxe K
    Brain Res; 1992 Jul; 584(1-2):157-62. PubMed ID: 1325243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
    Girault JA; Spampinato U; Glowinski J; Besson MJ
    Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study.
    Przedborski S; Kostic V; Jackson-Lewis V; Cadet JL; Burke RE
    J Neurochem; 1991 Dec; 57(6):1951-61. PubMed ID: 1834800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
    Maloteaux JM; Vanisberg MA; Laterre C; Javoy-Agid F; Agid Y; Laduron PM
    Eur J Pharmacol; 1988 Nov; 156(3):331-40. PubMed ID: 3215281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.